Abstract
Balanced and safe prescribing is difficult to achieve in frail older adults with multiple comorbid diseases. For this reason, great efforts have been made in the search for interventions to improve efficacy, safety and appropriateness of prescriptions in this vulnerable population. Among these interventions, the avoidance of medications that are considered to be inappropriate, i.e. potentially inappropriate medications (PIMs), has been considered a valuable treatment option. The aim of the present review was to summarize evidence about the use of explicit criteria for PIMs to reduce the risk of adverse drug reactions (ADRs) in older people. A PIM is a drug in which the risk of an adverse event outweighs its clinical benefit, particularly when there is evidence in favour of a safer or more effective alternative therapy for the same condition. Explicit criteria have been developed to identify PIMs, and among these, the Beers criteria have been the most frequently applied until recently. However, evidence suggests that such criteria can not easily be applied in European countries: several drugs listed in the 2003 Beers criteria were rarely prescribed or were not available in Europe and 2003 Beers-listed PIMs were not associated with ADRs in some studies. In the past few years, START/STOPP criteria have been developed and applied in several different studies and populations showing a greater ability to predict ADRs with respect to Beers criteria and to prevent potentially inappropriate prescribing. In 2012, Beers criteria have been updated using an evidence-based approach and future studies will investigate the impact of these and other criteria coming from ongoing studies on clinical outcomes relevant to geriatric populations.
Similar content being viewed by others
References
Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002 Jan 16; 287 (3): 337–44
Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010; 17 (6): 571–84
Van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007 Mar 21; 297 (11): 1233–40
Pedone C, Lapane KL. Generalizability of guidelines and physicians’ adherence. Case study on the Sixth Joint National Commitee’s guidelines on hypertension. BMC Public Health 2003 Jul 21; 3: 24
Boyd CM, Darer J, Boult C, et al. Clinical practice guide-lines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005 Aug 10; 294 (6): 716–24
Merle L, Laroche ML, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005; 22 (5): 375–92
Laroche ML, Charmes JP, Bouthier F, et al. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009 Jan; 85 (1): 94–7
Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001 Feb; 49 (2): 200–9
Gurwitz JH. Suboptimal medication use in the elderly. The tip of the iceberg. JAMA 1994 Jul 27; 272 (4): 316–7
Schmader K, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994 Dec; 42 (12): 1241–7
Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991 Sep; 151 (9): 1825–32
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997 Jul 28; 157 (14): 1531–6
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163 (22): 2716–24
American Geriatrics Society. Updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012 Apr; 60 (4): 616–31
Morandi A, Vasilevskis EE, Pandharipande PP, et al. Inappropriate medications in elderly ICU survivors: where to intervene? Arch Intern Med 2011 Jun 13; 171 (11): 1032–4
Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007 Jul 14; 370 (9582): 173–84
Fu AZ, Liu GG, Christensen DB. Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc 2004 Nov; 52 (11): 1934–9
Zuckerman IH, Langenberg P, Baumgarten M, et al. Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med Care 2006 Aug; 44 (8): 722–30
Perri 3rd M, Menon AM, Deshpande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005 Mar; 39 (3): 405–11
Chang CM, Liu PY, Yang YH, et al. Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy 2005 Jun; 25 (6): 831–8
Lau DT, Kasper JD, Potter DE, et al. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005 Jan 10; 165 (1): 68–74
Landi F, Russo A, Liperoti R, et al. Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol 2007 Aug; 63 (8): 791–9
Gupta S, Rappaport HM, Bennett LT. Inappropriate drug prescribing and related outcomes for elderly medicaid beneficiaries residing in nursing homes. Clin Ther 1996 Jan–Feb; 18 (1): 183–96
Laroche ML, Charmes JP, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007 Feb; 63 (2): 177–86
Franic DM, Jiang JZ. Potentially inappropriate drug use and health-related quality of life in the elderly. Pharmacotherapy 2006 Jun; 26 (6): 768–78
Rask KJ, Wells KJ, Teitel GS, et al. Can an algorithm for appropriate prescribing predict adverse drug events? Am J Manag Care 2005 Mar; 11 (3): 145–51
Raivio MM, Laurila JV, Strandberg TE, et al. Use of inappropriate medications and their prognostic significance among in-hospital and nursing home patients with and without dementia in Finland. Drugs Aging 2006; 23 (4): 333–43
Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005 Jul; 61 (5–6): 453–9
Aparasu RR, Mort JR. Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am J Geriatr Pharmacother 2004 Jun; 2 (2): 102–11
Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002 Feb; 40 (2): 166–76
Fillenbaum GG, Hanlon JT, Landerman LR, et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother 2004 Jun; 2 (2): 92–101
Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005; 22 (1): 69–82
Corsonello A, Pedone C, Lattanzio F, et al. Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc 2009 Jun; 57 (6): 1007–14
Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999 Jul 14; 282 (2): 113–5
O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008 Mar; 37 (2): 138–41
Gallagher PF, Barry PJ, Ryan C, et al. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers’ criteria. Age Ageing 2008 Jan; 37 (1): 96–101
Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation — executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006 Aug 15; 48 (4): 854–906
Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007 Apr; 32 (2): 113–21
Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med 2002 Aug 12–26; 162 (15): 1707–12
Kunin CM. Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated? Arch Intern Med 2004 Aug 9–23; 164 (15): 1701
Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005 Mar 16; 293 (11): 1348–58
Lechevallier N, Fourrier A, Berr C. [Benzodiazepine use in the elderly: the EVA Study]. Rev Epidemiol Sante Publique 2003 Jun; 51 (3): 317–26
Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999 Jul; 15 (1): 15–28
Prudent M, Drame M, Jolly D, et al. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort. Drugs Aging 2008; 25 (11): 933–46
Corsonello A, Pedone C, Corica F, et al. Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 2005 Sep; 60 (9): 1147–51
Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005 Apr 11; 165 (7): 790–5
Corsonello A, Pedone C, Corica F, et al. Estimating glomerular filtration rate might help to avoid hypoglycemia. J Am Geriatr Soc 2006 Sep; 54 (9): 1469–70
Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007 May; 55 (5): 658–65
Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008 Feb; 46 (2): 72–83
Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012 Jun 1; 29 (6): 463–75
Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008 Nov; 37 (6): 673–9
Ryan C, O’Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother 2009 Jul; 43 (7): 1239–44
Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 2011 Nov; 67 (11): 1175–88
Ryan C, O’Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in older residents in Irish nursing homes. Age Ageing 2012 Jul 24 [Epub ahead to print]
Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011 Jun 13; 171 (11): 1013–9
Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011 Jun; 89 (6): 845–54
Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004 Dec 30; 351 (27): 2870–4
Onder G, Lattanzio F, Battaglia M, et al. The risk of adverse drug reactions in older patients: beyond drug metabolism. Curr Drug Metab 2011 Sep; 12 (7): 647–51
Fusco D, Lattanzio F, Tosato M, et al. Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: rationale and methodology. Drugs Aging 2009 Dec; 26 Suppl. 1: 3–13
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corsonello, A., Onder, G., Abbatecola, A.M. et al. Explicit Criteria for Potentially Inappropriate Medications to Reduce the Risk of Adverse Drug Reactions in Elderly People. Drug Saf 35 (Suppl 1), 21–28 (2012). https://doi.org/10.1007/BF03319100
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03319100